Quidelortho Corp
Could not find a ticker for this position, may be a filing error
A maker of medical diagnostic tests, QuidelOrtho supplies the rapid tests and lab analyzers doctors, hospitals, and blood banks use to spot illness and match blood types. It was born in 2022 when two companies merged: Quidel, founded in San Diego in 1979, and Ortho Clinical Diagnostics, whose roots reach back to 1939 as a Johnson & Johnson division that helped pioneer safe blood transfusions. Its Sofia analyzer—named for its fluorescent rapid-testing system—won a Good Design award for its small, user-friendly design.
3.25% Convertible Bond due 12/15/2020
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| Newtyn Management, LLC | 13G/APassive | 9.7% | 6.63M | Aug 14, 2026 |
| Newtyn TE Partners, LP | 13G/APassive | 6.3% | 4.27M | Aug 14, 2026 |
| T. Rowe Price Investment Management, Inc. | 13G/APassive | 2.6% | 1.74M | Aug 14, 2026 |
| Invesco Ltd. | 13GPassive | 5.1% | 3.47M | Aug 13, 2026 |
| Neuberger Berman Group LLC | 13G/APassive | 4.9% | 3.38M | Aug 5, 2026 |
| Neuberger Berman Investment Advisers LLC | 13G/APassive | 4.4% | 3.03M | Aug 5, 2026 |
| FMR LLC | 13G/APassive | 11.5% | 7.85M | May 7, 2026 |
| Abigail P. Johnson | 13G/APassive | 11.5% | 7.85M | May 7, 2026 |
| Vanguard Capital Management | 13GPassive | 5.24% | 3.57M | Apr 30, 2026 |
| Vanguard Portfolio Management | 13GPassive | 6% | 4.09M | Apr 29, 2026 |